Cargando…
The Regulation of Alfalfa Saponin Extract on Key Genes Involved in Hepatic Cholesterol Metabolism in Hyperlipidemic Rats
To investigate the cholesterol-lowering effects of alfalfa saponin extract (ASE) and its regulation mechanism on some key genes involved in cholesterol metabolism, 40 healthy 7 weeks old male Sprague Dawley (SD) rats were randomly divided into four groups with 10 rats in each group: control group, h...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3914959/ https://www.ncbi.nlm.nih.gov/pubmed/24505463 http://dx.doi.org/10.1371/journal.pone.0088282 |
_version_ | 1782302501502976000 |
---|---|
author | Shi, Yinghua Guo, Rui Wang, Xianke Yuan, Dedi Zhang, Senhao Wang, Jie Yan, Xuebing Wang, Chengzhang |
author_facet | Shi, Yinghua Guo, Rui Wang, Xianke Yuan, Dedi Zhang, Senhao Wang, Jie Yan, Xuebing Wang, Chengzhang |
author_sort | Shi, Yinghua |
collection | PubMed |
description | To investigate the cholesterol-lowering effects of alfalfa saponin extract (ASE) and its regulation mechanism on some key genes involved in cholesterol metabolism, 40 healthy 7 weeks old male Sprague Dawley (SD) rats were randomly divided into four groups with 10 rats in each group: control group, hyperlipidemic group, ASE treatment group, ASE prevention group. The body weight gain, relative liver weight and serum lipid 1evels of rats were determined. Total cholesterol (TC) and total bile acids (TBA) levels in liver and feces were also measured. Furthermore, the activity and mRNA expressions of Hmgcr, Acat2, Cyp7a1 and Ldlr were investigated. The results showed the following: (1) The abnormal serum lipid levels in hyperlipidemic rats were ameliorated by ASE administration (both ASE prevention group and treatment group) (P<0.05). (2) Both ASE administration to hyperlipidemic rats significantly reduced liver TC and increased liver TBA level (P<0.05). TC and TBA levels in feces of hyperlipidemic rats were remarkably elevated by both ASE administration (P<0.05). (3) mRNA expressions of Hmgcr and Acat2 in the liver of hyperlipidemic rats were remarkably down-regulated (P<0.05), as well as mRNA expressions of Cyp7a1 and Ldlr were dramatically up-regulated by both ASE administration (P<0.05). The activities of these enzymes also paralleled the observed changes in mRNA levels. (4) There was no significant difference between ASE treatment and ASE prevention group for most parameters evaluated. Our present study indicated that ASE had cholesterol-lowering effects. The possible mechanism could be attributed to (1) the down-regulation of Hmgcr and Acat2, as well as up-regulation of Cyp7a1 and Ldlr in the liver of hyperlipidemic rats, which was involved in cholesterol biosynthesis, uptake, and efflux pathway; (2) the increase in excretion of cholesterol. The findings in our study suggested ASE had great potential usefulness as a natural agent for treating hyperlipidemia. |
format | Online Article Text |
id | pubmed-3914959 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-39149592014-02-06 The Regulation of Alfalfa Saponin Extract on Key Genes Involved in Hepatic Cholesterol Metabolism in Hyperlipidemic Rats Shi, Yinghua Guo, Rui Wang, Xianke Yuan, Dedi Zhang, Senhao Wang, Jie Yan, Xuebing Wang, Chengzhang PLoS One Research Article To investigate the cholesterol-lowering effects of alfalfa saponin extract (ASE) and its regulation mechanism on some key genes involved in cholesterol metabolism, 40 healthy 7 weeks old male Sprague Dawley (SD) rats were randomly divided into four groups with 10 rats in each group: control group, hyperlipidemic group, ASE treatment group, ASE prevention group. The body weight gain, relative liver weight and serum lipid 1evels of rats were determined. Total cholesterol (TC) and total bile acids (TBA) levels in liver and feces were also measured. Furthermore, the activity and mRNA expressions of Hmgcr, Acat2, Cyp7a1 and Ldlr were investigated. The results showed the following: (1) The abnormal serum lipid levels in hyperlipidemic rats were ameliorated by ASE administration (both ASE prevention group and treatment group) (P<0.05). (2) Both ASE administration to hyperlipidemic rats significantly reduced liver TC and increased liver TBA level (P<0.05). TC and TBA levels in feces of hyperlipidemic rats were remarkably elevated by both ASE administration (P<0.05). (3) mRNA expressions of Hmgcr and Acat2 in the liver of hyperlipidemic rats were remarkably down-regulated (P<0.05), as well as mRNA expressions of Cyp7a1 and Ldlr were dramatically up-regulated by both ASE administration (P<0.05). The activities of these enzymes also paralleled the observed changes in mRNA levels. (4) There was no significant difference between ASE treatment and ASE prevention group for most parameters evaluated. Our present study indicated that ASE had cholesterol-lowering effects. The possible mechanism could be attributed to (1) the down-regulation of Hmgcr and Acat2, as well as up-regulation of Cyp7a1 and Ldlr in the liver of hyperlipidemic rats, which was involved in cholesterol biosynthesis, uptake, and efflux pathway; (2) the increase in excretion of cholesterol. The findings in our study suggested ASE had great potential usefulness as a natural agent for treating hyperlipidemia. Public Library of Science 2014-02-05 /pmc/articles/PMC3914959/ /pubmed/24505463 http://dx.doi.org/10.1371/journal.pone.0088282 Text en © 2014 Shi et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Shi, Yinghua Guo, Rui Wang, Xianke Yuan, Dedi Zhang, Senhao Wang, Jie Yan, Xuebing Wang, Chengzhang The Regulation of Alfalfa Saponin Extract on Key Genes Involved in Hepatic Cholesterol Metabolism in Hyperlipidemic Rats |
title | The Regulation of Alfalfa Saponin Extract on Key Genes Involved in Hepatic Cholesterol Metabolism in Hyperlipidemic Rats |
title_full | The Regulation of Alfalfa Saponin Extract on Key Genes Involved in Hepatic Cholesterol Metabolism in Hyperlipidemic Rats |
title_fullStr | The Regulation of Alfalfa Saponin Extract on Key Genes Involved in Hepatic Cholesterol Metabolism in Hyperlipidemic Rats |
title_full_unstemmed | The Regulation of Alfalfa Saponin Extract on Key Genes Involved in Hepatic Cholesterol Metabolism in Hyperlipidemic Rats |
title_short | The Regulation of Alfalfa Saponin Extract on Key Genes Involved in Hepatic Cholesterol Metabolism in Hyperlipidemic Rats |
title_sort | regulation of alfalfa saponin extract on key genes involved in hepatic cholesterol metabolism in hyperlipidemic rats |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3914959/ https://www.ncbi.nlm.nih.gov/pubmed/24505463 http://dx.doi.org/10.1371/journal.pone.0088282 |
work_keys_str_mv | AT shiyinghua theregulationofalfalfasaponinextractonkeygenesinvolvedinhepaticcholesterolmetabolisminhyperlipidemicrats AT guorui theregulationofalfalfasaponinextractonkeygenesinvolvedinhepaticcholesterolmetabolisminhyperlipidemicrats AT wangxianke theregulationofalfalfasaponinextractonkeygenesinvolvedinhepaticcholesterolmetabolisminhyperlipidemicrats AT yuandedi theregulationofalfalfasaponinextractonkeygenesinvolvedinhepaticcholesterolmetabolisminhyperlipidemicrats AT zhangsenhao theregulationofalfalfasaponinextractonkeygenesinvolvedinhepaticcholesterolmetabolisminhyperlipidemicrats AT wangjie theregulationofalfalfasaponinextractonkeygenesinvolvedinhepaticcholesterolmetabolisminhyperlipidemicrats AT yanxuebing theregulationofalfalfasaponinextractonkeygenesinvolvedinhepaticcholesterolmetabolisminhyperlipidemicrats AT wangchengzhang theregulationofalfalfasaponinextractonkeygenesinvolvedinhepaticcholesterolmetabolisminhyperlipidemicrats AT shiyinghua regulationofalfalfasaponinextractonkeygenesinvolvedinhepaticcholesterolmetabolisminhyperlipidemicrats AT guorui regulationofalfalfasaponinextractonkeygenesinvolvedinhepaticcholesterolmetabolisminhyperlipidemicrats AT wangxianke regulationofalfalfasaponinextractonkeygenesinvolvedinhepaticcholesterolmetabolisminhyperlipidemicrats AT yuandedi regulationofalfalfasaponinextractonkeygenesinvolvedinhepaticcholesterolmetabolisminhyperlipidemicrats AT zhangsenhao regulationofalfalfasaponinextractonkeygenesinvolvedinhepaticcholesterolmetabolisminhyperlipidemicrats AT wangjie regulationofalfalfasaponinextractonkeygenesinvolvedinhepaticcholesterolmetabolisminhyperlipidemicrats AT yanxuebing regulationofalfalfasaponinextractonkeygenesinvolvedinhepaticcholesterolmetabolisminhyperlipidemicrats AT wangchengzhang regulationofalfalfasaponinextractonkeygenesinvolvedinhepaticcholesterolmetabolisminhyperlipidemicrats |